Subsequent microarray analyses have identified RGC-32 as a gene expressed at low level in multiple myeloma plasma cells and drug resistant glioblastomas and RGC-32 promoter methylation has been shown to correlate with RGC-32 downregulation in non small cell lung cancers [35]–[37]. This evidence concerns the gene RGCC and glioblastoma.